Because schizophrenia-associated genes represent promising candidates for predicting antidepressant efficacy, Su and others have tested five PTPRZ1 SNPs for an association with anxiety remission status in two Chinese cohorts that were stratified for the medication received, but correction for multiple testing aborted the potential associations (Su et al., 2021a). The gene discussed is PTPRZ1; the disease is schizophrenia.